ABVC BioPharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures
ABVC BioPharma, Inc. (ECOC) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures of 5.00 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures · last filed 2024-03-13
- ABVC BioPharma, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, forfeitures for fiscal 2022 was 5.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 12 month |
|---|---|
| 2022-12-31 | 5.00M shares 10-K · filed 2024-03-13 |